US6171782B1
(en)
|
1987-11-18 |
2001-01-09 |
Chiron Corporation |
Antibody compositions to HCV and uses thereof
|
US5714596A
(en)
*
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
US5698390A
(en)
*
|
1987-11-18 |
1997-12-16 |
Chiron Corporation |
Hepatitis C immunoassays
|
US5712088A
(en)
*
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
US6861212B1
(en)
|
1987-11-18 |
2005-03-01 |
Chiron Corporation |
NANBV diagnostics and vaccines
|
US5350671A
(en)
*
|
1987-11-18 |
1994-09-27 |
Chiron Corporation |
HCV immunoassays employing C domain antigens
|
US5827821A
(en)
*
|
1987-12-10 |
1998-10-27 |
The Burnham Institute |
Conformationally stabilized cell adhesion peptides
|
EP0731110A1
(de)
*
|
1987-12-10 |
1996-09-11 |
La Jolla Cancer Research Foundation |
Verfahren zur Herstellung von konformationell stabilisierten Zelladhäsionspeptiden
|
US6124107A
(en)
*
|
1988-06-10 |
2000-09-26 |
Merck & Co., Inc. |
Assay for marker of human polymorphonuclear leukocyte elastase activity
|
US6027729A
(en)
*
|
1989-04-20 |
2000-02-22 |
Chiron Corporation |
NANBV Diagnostics and vaccines
|
US5582968A
(en)
*
|
1990-02-16 |
1996-12-10 |
United Biomedical, Inc. |
Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
US5639594A
(en)
*
|
1990-02-16 |
1997-06-17 |
United Biomedical, Inc. |
Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
US5648330A
(en)
*
|
1990-04-06 |
1997-07-15 |
La Jolla Cancer Research Foundation |
Method and composition for treating vascular graft occlusion
|
JPH05509294A
(ja)
*
|
1990-04-06 |
1993-12-22 |
ラ ホヤ キャンサー リサーチ ファウンデーション |
血栓症治療のための方法および組成物
|
US5672585A
(en)
*
|
1990-04-06 |
1997-09-30 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
US6521594B1
(en)
|
1990-04-06 |
2003-02-18 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
US5612311A
(en)
|
1990-04-06 |
1997-03-18 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
US5780303A
(en)
*
|
1990-04-06 |
1998-07-14 |
La Jolla Cancer Research Foundation |
Method and composition for treating thrombosis
|
WO1992009634A1
(en)
*
|
1990-11-29 |
1992-06-11 |
Toray Industries, Incorporated |
Non-a non-b hepatitis virus antigen protein
|
ES2095852T3
(es)
*
|
1990-12-14 |
1997-03-01 |
Innogenetics Nv |
Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
|
US5574132A
(en)
*
|
1991-04-05 |
1996-11-12 |
Biochem Immunosystems Inc. |
Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
|
WO1992019743A2
(en)
*
|
1991-05-08 |
1992-11-12 |
Chiron Corporation |
Hcv genomic sequences for diagnostics and therapeutics
|
US6190864B1
(en)
|
1991-05-08 |
2001-02-20 |
Chiron Corporation |
HCV genomic sequences for diagnostics and therapeutics
|
HU227547B1
(en)
*
|
1991-06-24 |
2011-08-29 |
Novartis Vaccines & Diagnostic |
Hepatitis c virus (hcv) polypeptides
|
DE4209215A1
(de)
*
|
1991-07-04 |
1993-01-07 |
Boehringer Mannheim Gmbh |
Hcv peptidantigene und verfahren zur bestimmung von hcv
|
WO1993009253A1
(en)
*
|
1991-11-07 |
1993-05-13 |
Baxter Diagnostics Inc. |
Epitope mapping ot the c33c region of hcv
|
WO1993011158A2
(en)
*
|
1991-12-06 |
1993-06-10 |
Akzo Nobel N.V. |
Non-a, non-b peptides
|
JPH05176773A
(ja)
*
|
1991-12-27 |
1993-07-20 |
Imuno Japan:Kk |
オリゴヌクレオチド、オリゴペプタイド、ならびに抗c型肝 炎ウイルス抗体検出・鑑別方法
|
US7611713B2
(en)
|
1993-03-05 |
2009-11-03 |
Pharmexa Inc. |
Inducing cellular immune responses to hepatitis B virus using peptide compositions
|
US6709828B1
(en)
|
1992-03-06 |
2004-03-23 |
N.V. Innogenetics S.A. |
Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
|
US6667387B1
(en)
|
1996-09-30 |
2003-12-23 |
N.V. Innogenetics S.A. |
HCV core peptides
|
UA39944C2
(uk)
*
|
1992-07-07 |
2001-07-16 |
Чірон Корпорейшн |
Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
|
US6153378A
(en)
*
|
1992-10-16 |
2000-11-28 |
Bionova Corporation |
Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
|
JP2778886B2
(ja)
*
|
1992-10-16 |
1998-07-23 |
エバーニュー バイオテック インコーポレイティド |
C型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
|
WO1994024565A1
(en)
*
|
1993-04-22 |
1994-10-27 |
Genelabs Technologies, Inc. |
Hepatitis c virus immunodiagnostic antigens and antibodies
|
DE4402756A1
(de)
*
|
1994-01-31 |
1995-08-03 |
Boehringer Mannheim Gmbh |
Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine
|
AU2352995A
(en)
*
|
1995-04-28 |
1996-11-18 |
Srl Inc. |
Antigen peptide compound and immunoassay method
|
US5616460A
(en)
*
|
1995-06-07 |
1997-04-01 |
Abbott Laboratories |
Buffer composition for reagents for immunoassay
|
US6127116A
(en)
|
1995-08-29 |
2000-10-03 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
US7235394B1
(en)
|
1995-08-29 |
2007-06-26 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
US7785842B2
(en)
*
|
1996-03-26 |
2010-08-31 |
Oncomedx, Inc. |
Comparative analysis of extracellular RNA species
|
US8043835B1
(en)
|
1996-03-26 |
2011-10-25 |
Oncomedx, Inc. |
Methods for detecting and monitoring cancer using extracellular RNA
|
PT938320E
(pt)
*
|
1996-03-26 |
2010-09-22 |
Michael S Kopreski |
Método que permite a utilização de arn extracelular extraído de plasma ou de soro para detectar, monitorizar ou avaliar o cancro
|
KR19980069021A
(ko)
*
|
1997-02-26 |
1998-10-26 |
성재갑 |
히스티딘이 표지된 한국형 c 형 간염 바이러스의 비구조 단백질 3 및 그의 제조방법
|
US7338759B1
(en)
|
1997-03-04 |
2008-03-04 |
Washington University |
HCV variants
|
US7049428B1
(en)
*
|
1998-03-04 |
2006-05-23 |
Washington University |
HCV variants
|
US8440396B2
(en)
*
|
1997-03-14 |
2013-05-14 |
Oncomedx, Inc. |
Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
|
US6143496A
(en)
|
1997-04-17 |
2000-11-07 |
Cytonix Corporation |
Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
|
US6030771A
(en)
*
|
1997-08-25 |
2000-02-29 |
Centers For Disease Control And Prevention |
Mosaic protein and restriction endonuclease assisted ligation method for making the same
|
WO1999029321A1
(en)
|
1997-12-11 |
1999-06-17 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Inhibition of membrane-associated viral replication
|
US6465488B1
(en)
|
1997-12-11 |
2002-10-15 |
Chancellor, Masters & Scholars Of The University Of Oxford |
Inhibition of glycolipid biosynthesis
|
FR2775690B1
(fr)
*
|
1998-03-09 |
2001-12-14 |
Bio Merieux |
Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
|
DE69934810T2
(de)
*
|
1998-06-09 |
2007-10-11 |
Branch, Andrea D. |
Neues hepatitis c viruspeptid und seine verwendung
|
US7052830B1
(en)
*
|
1998-06-09 |
2006-05-30 |
Branch Andrea D |
Hepatitis C virus peptides and uses thereof
|
US20090233276A1
(en)
*
|
1998-09-22 |
2009-09-17 |
Oncomedx, Inc. |
Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
|
US7091324B2
(en)
|
1998-11-05 |
2006-08-15 |
Board Of Trustees Of Leland Stanford Junior University |
Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
EP1178116A1
(de)
*
|
2000-08-03 |
2002-02-06 |
Hybrigenics S.A. |
Sid nukleische Saüre und aus einem pathogenischen Stamm des Hepatitis C Viruses selektierte Polypeptide und deren Verwendungenthereof
|
US7101683B2
(en)
*
|
2001-06-26 |
2006-09-05 |
Abbott Laboratories |
Methods for the simultaneous detection of HCV antigens and HCV antibodies
|
CA2450710C
(en)
*
|
2001-06-26 |
2013-11-26 |
Abbott Laboratories |
Methods for the simultaneous detection of hcv antigens and hcv antibodies
|
EP1435974A4
(de)
*
|
2001-09-28 |
2006-09-06 |
Idenix Cayman Ltd |
Verfahren und zusamemnsetzungen zur behandlung des hepatitis-c-virus mit 4'-modifizierten nucleosiden
|
US20100159464A1
(en)
*
|
2001-11-05 |
2010-06-24 |
Oncomedx, Inc. |
Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
|
RS114004A
(en)
|
2002-06-28 |
2007-02-05 |
Idenix (Cayman) Limited, |
Modified 2' and 3'-nucleoside produgs for treating flaviridae infections
|
EP2345661A1
(de)
|
2003-05-30 |
2011-07-20 |
Pharmasset, Inc. |
Modifizierte fluorinierte Nukleosidanaloga
|
US20050202036A1
(en)
*
|
2003-07-22 |
2005-09-15 |
Branch Andrea D. |
Alternate reading frame polypeptides drived from hepatitis C and methods of their use
|
DK1658302T3
(da)
|
2003-07-25 |
2010-11-22 |
Idenix Pharmaceuticals Inc |
Purinnukleosidanaloge til behandling af sygdomme forårsaget af Flavirividae, herunder hepatitis C
|
GB0500020D0
(en)
|
2005-01-04 |
2005-02-09 |
Novartis Ag |
Organic compounds
|
AP2715A
(en)
*
|
2004-06-04 |
2013-07-31 |
Bioniche Life Sciences Inc |
Use of imatinib to treat liver disorders and viralinfections
|
CN101023094B
(zh)
*
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
AU2005285045B2
(en)
*
|
2004-09-14 |
2011-10-13 |
Gilead Pharmasset Llc |
Preparation of 2'fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
KR20080033274A
(ko)
|
2005-06-17 |
2008-04-16 |
노파르티스 아게 |
Hcv에서 상글리페린의 용도
|
CN101466727B
(zh)
|
2006-04-11 |
2012-10-17 |
诺瓦提斯公司 |
Hcv/hiv抑制剂及其用途
|
ATE530669T1
(de)
*
|
2006-05-19 |
2011-11-15 |
Danisco |
Markierte mikroorganismen und entsprechende markierungsverfahren
|
PL2144604T3
(pl)
*
|
2007-02-28 |
2012-02-29 |
Conatus Pharmaceuticals Inc |
Sposoby leczenia przewlekłego zapalenia wątroby typu C z zastosowaniem RO 113-0830
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
ES2437147T3
(es)
|
2008-02-04 |
2014-01-09 |
Idenix Pharmaceuticals, Inc. |
Inhibidores de serina proteasa macrocíclicos
|
JP2011510672A
(ja)
*
|
2008-02-08 |
2011-04-07 |
インターツェル・アクチェンゲゼルシャフト |
ワクチンとして使用するための、カプシドタンパク質中に欠失を含むフラビウイルス科突然変異体
|
TW200946541A
(en)
*
|
2008-03-27 |
2009-11-16 |
Idenix Pharmaceuticals Inc |
Solid forms of an anti-HIV phosphoindole compound
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
AU2009277172B2
(en)
|
2008-07-02 |
2014-05-29 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
AR074897A1
(es)
*
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
AU2009329872B2
(en)
|
2008-12-23 |
2016-07-07 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
SG172361A1
(en)
*
|
2008-12-23 |
2011-07-28 |
Pharmasset Inc |
Nucleoside analogs
|
US8102720B2
(en)
*
|
2009-02-02 |
2012-01-24 |
Qualcomm Incorporated |
System and method of pulse generation
|
US8193372B2
(en)
|
2009-03-04 |
2012-06-05 |
Idenix Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole HCV polymerase inhibitors
|
TW201040181A
(en)
|
2009-04-08 |
2010-11-16 |
Idenix Pharmaceuticals Inc |
Macrocyclic serine protease inhibitors
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
WO2011017389A1
(en)
|
2009-08-05 |
2011-02-10 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
|
WO2011063076A1
(en)
|
2009-11-19 |
2011-05-26 |
Itherx Pharmaceuticals, Inc. |
Methods of treating hepatitis c virus with oxoacetamide compounds
|
SG181797A1
(en)
|
2009-12-18 |
2012-07-30 |
Idenix Pharmaceuticals Inc |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
EP2752422B1
(de)
|
2010-03-31 |
2017-08-16 |
Gilead Pharmasset LLC |
Stereoselektive synthese von phosphorhaltigen wirkstoffen
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
MX2012011222A
(es)
|
2010-04-01 |
2013-01-18 |
Centre Nat Rech Scient |
Compuestos y composiciones farmaceuticas para el tratamiento de infecciones virales.
|
AU2011311880B2
(en)
|
2010-10-08 |
2014-07-24 |
Novartis Ag |
Vitamin E formulations of sulfamide NS3 inhibitors
|
ES2716158T3
(es)
|
2010-11-30 |
2019-06-10 |
Gilead Pharmasset Llc |
2'-spiro-nucleótidos para el tratamiento de hepatitis C
|
WO2012109398A1
(en)
|
2011-02-10 |
2012-08-16 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
|
WO2012154321A1
(en)
|
2011-03-31 |
2012-11-15 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
TW201329096A
(zh)
|
2011-09-12 |
2013-07-16 |
Idenix Pharmaceuticals Inc |
經取代羰氧基甲基磷酸醯胺化合物及用於治療病毒感染之藥學組成物
|
JP2014526474A
(ja)
|
2011-09-12 |
2014-10-06 |
アイディニックス ファーマシューティカルズ インコーポレイテッド |
ウイルス感染の治療のための化合物および薬学的組成物
|
EP2768838A1
(de)
|
2011-10-14 |
2014-08-27 |
IDENIX Pharmaceuticals, Inc. |
Substituierte 3 ', 5 '-cyclophosphate von purin-nukleotid-verbindungen und pharmazeutische zusammensetzungen für die behandlung von virusinfektionen
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
US9089574B2
(en)
|
2011-11-30 |
2015-07-28 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
US8809354B2
(en)
|
2011-12-31 |
2014-08-19 |
Sheikh Riazuddin |
3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
|
US20130217644A1
(en)
|
2012-02-13 |
2013-08-22 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate]
|
EP2852604B1
(de)
|
2012-05-22 |
2017-04-12 |
Idenix Pharmaceuticals LLC |
3',5'-cyclische phosphoramidat-prodrugs für hcv-infektion
|
WO2013177195A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphate prodrugs for hcv infection
|
NZ702744A
(en)
|
2012-05-22 |
2016-12-23 |
Idenix Pharmaceuticals Llc |
D-amino acid compounds for liver disease
|
EA030189B8
(ru)
|
2012-10-08 |
2018-10-31 |
Иденикс Фармасьютикалз Ллс |
Аналоги 2'-хлоронуклеозидов для инфекции вгс
|
US20140112886A1
(en)
|
2012-10-19 |
2014-04-24 |
Idenix Pharmaceuticals, Inc. |
Dinucleotide compounds for hcv infection
|
US10723754B2
(en)
|
2012-10-22 |
2020-07-28 |
Idenix Pharmaceuticals Llc |
2′,4′-bridged nucleosides for HCV infection
|
WO2014078427A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-alanine ester of rp-nucleoside analog
|
EP2938624A1
(de)
|
2012-11-14 |
2015-11-04 |
IDENIX Pharmaceuticals, Inc. |
D-alaninester von sp-nukleosidanalogon
|
WO2014099941A1
(en)
|
2012-12-19 |
2014-06-26 |
Idenix Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
US9339541B2
(en)
|
2013-03-04 |
2016-05-17 |
Merck Sharp & Dohme Corp. |
Thiophosphate nucleosides for the treatment of HCV
|
US9309275B2
(en)
|
2013-03-04 |
2016-04-12 |
Idenix Pharmaceuticals Llc |
3′-deoxy nucleosides for the treatment of HCV
|
US9187515B2
(en)
|
2013-04-01 |
2015-11-17 |
Idenix Pharmaceuticals Llc |
2′,4′-fluoro nucleosides for the treatment of HCV
|
US10005779B2
(en)
|
2013-06-05 |
2018-06-26 |
Idenix Pharmaceuticals Llc |
1′,4′-thio nucleosides for the treatment of HCV
|
WO2015017713A1
(en)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
ES2900570T3
(es)
|
2013-08-27 |
2022-03-17 |
Gilead Pharmasset Llc |
Formulación de combinación de dos compuestos antivirales
|
US20160229866A1
(en)
|
2013-09-20 |
2016-08-11 |
Idenix Pharmaceuticals Inc. |
Hepatitis c virus inhibitors
|
WO2015061683A1
(en)
|
2013-10-25 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate and d-alanine thiophosphoramidate pronucleotides of nucleoside compounds useful for the treatment of hcv
|
WO2015066370A1
(en)
|
2013-11-01 |
2015-05-07 |
Idenix Pharmaceuticals, Inc. |
D-alanine phosphoramidate pronucleotides of 2'-methyl 2'-fluoro guanosine nucleoside compounds for the treatment of hcv
|
EP3074399A1
(de)
|
2013-11-27 |
2016-10-05 |
Idenix Pharmaceuticals LLC |
2'-dichlor- und 2'-fluor-2'-chlor-nukleosidanaloga für hcv-infektion
|
WO2015095419A1
(en)
|
2013-12-18 |
2015-06-25 |
Idenix Pharmaceuticals, Inc. |
4'-or nucleosides for the treatment of hcv
|
WO2015134561A1
(en)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection
|
EP3114122A1
(de)
|
2014-03-05 |
2017-01-11 |
Idenix Pharmaceuticals LLC |
Feste formen einer flaviviridae-virus-hemmerverbindung und salze davon
|
EP3113763A1
(de)
|
2014-03-05 |
2017-01-11 |
Idenix Pharmaceuticals LLC |
Feste prodrug-formen von 2'-chlor-2' -methyluridin für hcv
|
WO2015161137A1
(en)
|
2014-04-16 |
2015-10-22 |
Idenix Pharmaceuticals, Inc. |
3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
|